Lithium Therapy for Bipolar Depression

Guideline Recommendations

The American Academy of Child and Adolescent Psychiatry recommends maintaining serum lithium concentrations of 0.6-0.8 mmol/L for maintenance therapy, with this range representing consensus across multiple international clinical practice guidelines 1
For acute treatment of mania, higher concentrations of 0.8-1.2 mEq/L are recommended, though individual patients may respond at lower concentrations 1
Regular monitoring of lithium levels, renal function, thyroid function, and urinalysis every 3-6 months is essential for all patients on maintenance lithium therapy 1, 2

In elderly patients with dementia-related agitation, blood levels of 0.2 to 0.6 mEq/L are generally adequate and usually achieved with dosages of 150 to 300 mg per day 3
This recommendation applies specifically to elderly patients with Alzheimer's disease for anticycling or augmentation purposes, not as primary treatment for bipolar depression 3

Lithium has been associated with bradycardia, T wave changes, and AV-block, requiring cardiac monitoring in patients with pre-existing cardiac conditions 2
Withdrawal of maintenance lithium therapy is associated with increased relapse risk, especially within 6 months following discontinuation, with more than 90% of noncompliant adolescents relapsing compared to 37.5% of compliant patients 1
Inadequate duration of maintenance therapy leads to high relapse rates, making it essential to maintain therapeutic levels for at least 12-24 months after mood stabilization 1

All patients on lithium require baseline assessment: complete blood count, thyroid function tests, urinalysis, BUN, creatinine, serum calcium, and pregnancy test in females 1
Ongoing monitoring every 3-6 months must include: lithium levels, renal function, thyroid function, and urinalysis 1, 2
The American Academy of Child and Adolescent Psychiatry recommends olanzapine-fluoxetine combination as a first-line option for bipolar depression 1
Lamotrigine is FDA-approved for maintenance therapy and is particularly effective for preventing depressive episodes in bipolar disorder 1
If a patient is already stabilized on standard-dose lithium, adding lamotrigine or an antidepressant (always with a mood stabilizer) may be more appropriate than reducing lithium to subtherapeutic levels 1
Antidepressant monotherapy is contraindicated due to risk of mood destabilization and mania induction 1, 2